Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 95,507,008
  • Shares Outstanding, K 1,303,850
  • Annual Sales, $ 26,107 M
  • Annual Income, $ 4,628 M
  • 36-Month Beta 1.19
  • Price/Sales 3.63
  • Price/Cash Flow 7.56
  • Price/Book 4.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.87 +1.74%
on 04/02/18
76.25 -4.10%
on 04/12/18
-2.42 (-3.20%)
since 03/26/18
3-Month
71.87 +1.74%
on 04/02/18
89.54 -18.34%
on 01/29/18
-12.34 (-14.44%)
since 01/26/18
52-Week
63.76 +14.68%
on 06/16/17
89.54 -18.34%
on 01/29/18
+4.90 (+7.18%)
since 04/26/17

Most Recent Stories

More News
Syntimmune Appoints Andrew Cheng, M.D., Ph.D., to Board of Directors, Bolstering Clinical Development Expertise

Syntimmune, Inc., a clinical-stage biotechnology company developing antibody therapeutics targeting FcRn, today announced an expansion of its board of directors with the appointment...

GILD : 73.31 (+0.08%)
Stocks Drop as 10-Year Yield Touches 3%

Stocks Drop as 10-Year Yield Touches 3%

CTRP : 41.42 (+0.31%)
SYK : 165.38 (+0.41%)
SLB : 69.46 (+0.52%)
GILD : 73.31 (+0.08%)
BYD : 35.23 (+4.39%)
FNKO : 8.75 (+0.34%)
SINA : 91.62 (-1.30%)
Is a Beat in Store for Vertex (VRTX) This Earnings Season?

Vertex (VRTX) is expected to beat estimates when it reports its Q1 earnings on Apr 26.

CELG : 89.50 (+0.34%)
VRTX : 155.15 (-0.33%)
GILD : 73.31 (+0.08%)
AMGN : 174.83 (+1.68%)
Is a Beat in Store for Alexion (ALXN) This Earnings Season?

Impressive sales of Alexion's blockbuster drug, Soliris might lead the company toward an earnings beat in Q1.

ABBV : 94.35 (+2.70%)
GILD : 73.31 (+0.08%)
PFE : 36.72 (+0.11%)
ALXN : 114.00 (+7.51%)
Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy

Let's dig into the earnings picture of the companies that would drive the performance of the popular health care ETFs in the coming days.

XLV : 82.16 (+0.45%)
VHT : 154.68 (+0.34%)
MRK : 59.67 (+0.07%)
IYH : 173.68 (+0.38%)
FHLC : 40.06 (+0.20%)
ABBV : 94.35 (+2.70%)
GILD : 73.31 (+0.08%)
AMGN : 174.83 (+1.68%)
PFE : 36.72 (+0.11%)
BMY : 52.05 (+0.56%)
Is a Beat in Store for Bristol-Myers (BMY) in Q1 Earnings?

Bristol-Myers (BMY) is scheduled to report Q1 earnings on Apr 26.

ABBV : 94.35 (+2.70%)
GILD : 73.31 (+0.08%)
PFE : 36.72 (+0.11%)
BMY : 52.05 (+0.56%)
Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy

Let's dig into the earnings picture of the companies that would drive the performance of the popular health care ETFs in the coming days.

XLV : 82.16 (+0.45%)
VHT : 154.68 (+0.34%)
MRK : 59.67 (+0.07%)
IYH : 173.68 (+0.38%)
FHLC : 40.06 (+0.20%)
ABBV : 94.35 (+2.70%)
GILD : 73.31 (+0.08%)
AMGN : 174.83 (+1.68%)
PFE : 36.72 (+0.11%)
BMY : 52.05 (+0.56%)
The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research

The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research

PSX : 110.25 (+0.42%)
IBM : 146.35 (+0.28%)
LRCX : 189.30 (+1.41%)
GILD : 73.31 (+0.08%)
MCD : 156.25 (+0.20%)
Top Research Reports for IBM, McDonald's & Gilead

Top Research Reports for IBM, McDonald's & Gilead

CELG : 89.50 (+0.34%)
PSX : 110.25 (+0.42%)
IBM : 146.35 (+0.28%)
LRCX : 189.30 (+1.41%)
GILD : 73.31 (+0.08%)
MCD : 156.25 (+0.20%)
Watch for Gilead Sciences to Potentially Rebound After Falling 2.03% Yesterday

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $74.11 to a high of $75.92. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $74.24...

GILD : 73.31 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products...

See More

Key Turning Points

2nd Resistance Point 74.18
1st Resistance Point 73.72
Last Price 73.31
1st Support Level 72.63
2nd Support Level 72.00

See More

52-Week High 89.54
Fibonacci 61.8% 79.69
Fibonacci 50% 76.65
Fibonacci 38.2% 73.61
Last Price 73.31
52-Week Low 63.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar